This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Letters to the Editor

Long-Term Outcome of Vagus Nerve Stimulation in Rapid-Cycling Bipolar Disorder

Malek Bajbouj, MD; Heidi Danker-Hopfe, PhD; Isabella Heuser, PhD; and Ion Anghelescu, MD

Published: May 15, 2006

Article Abstract

Because this piece does not have an abstract, we have provided for your benefit the first 3 sentences of the full text.

Sir: The phenomenon of rapid cycling in patients with bipolar disorder has been identified as a marker for high risk of recurrence and resistance to conventional drug treatment.1 New anticonvulsants are promising agents for the treatment of bipolar disorders, but they are heterogeneous with regard to their efficacy, target symptoms, and adverse event profiles.2

Vagus nerve stimulation (VNS) therapy is delivered with a device (NCP System; Cyberonics, Houston, Tex.) and has received U.S. Food and Drug Administration approval for adjunctive long-term treatment of chronic or recurrent depression for patients who are experiencing a major depressive episode and have not had an adequate response to 4 or more adequate antidepressant treatments.’ ‹


Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Related Articles

Volume: 67

Quick Links: Bipolar Disorder

Sign-up to stay
up-to-date today!

SUBSCRIBE

Already registered? Sign In

Case Report

Safety and Tolerability of Concomitant Intranasal Esketamine Treatment With Irreversible, Nonselective MAOIs: A Case Series

Three cases suggest that concomitant use of intranasal esketamine with an irreversible, nonselective MAOI is safe in...

Read More...